Pathogenic Mechanisms of Neurodegeneration in Parkinson Disease

被引:103
作者
Mullin, Stephen [1 ]
Schapira, Anthony H. V. [1 ]
机构
[1] UCL Inst Neurol, Dept Clin Neurosci, London NW3 2PF, England
基金
英国惠康基金;
关键词
Parkinson disease; alpha-Synuclein; Lewy bodies; Mitochondrial dysfunction; AUTOSOMAL-DOMINANT PARKINSONISM; CHAPERONE-MEDIATED AUTOPHAGY; ALPHA-SYNUCLEIN AGGREGATION; G2019S LRRK2 MUTATION; LEWY BODY PATHOLOGY; GAUCHER-DISEASE; DOPAMINERGIC-NEURONS; SUBSTANTIA-NIGRA; COMPLEX-I; GENOMEWIDE ASSOCIATION;
D O I
10.1016/j.ncl.2014.09.010
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The last 2 decades represent a period of unparalleled advancement in the understanding of the pathogenesis of Parkinson disease (PD). The discovery of several forms of familial parkinsonism with mendelian inheritance has elucidated insights into the mechanisms underlying the degeneration of dopaminergic neurons of the substantia nigra that histologically characterize PD. alpha-Synuclein, the principal component of Lewy bodies, remains the presumed pathogen at the heart of the current model; however, concurrently, a diverse range of other mechanisms have been implicated. The creation of a coherent disease model will be crucial to the development of effective disease modifying therapies for sporadic PD.
引用
收藏
页码:1 / +
页数:18
相关论文
共 148 条
  • [1] Mice lacking α-synuclein display functional deficits in the nigrostriatal dopamine system
    Abeliovich, A
    Schmitz, Y
    Fariñas, I
    Choi-Lundberg, D
    Ho, WH
    Castillo, PE
    Shinsky, N
    Verdugo, JMG
    Armanini, M
    Ryan, A
    Hynes, M
    Phillips, H
    Sulzer, D
    Rosenthal, A
    [J]. NEURON, 2000, 25 (01) : 239 - 252
  • [2] Anglade P, 1997, HISTOL HISTOPATHOL, V12, P603
  • [3] Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers
    Anheim, M.
    Elbaz, A.
    Lesage, S.
    Durr, A.
    Condroyer, C.
    Viallet, F.
    Pollak, P.
    Bonaiti, B.
    Bonaiti-Pellie, C.
    Brice, A.
    [J]. NEUROLOGY, 2012, 78 (06) : 417 - 420
  • [4] Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease
    Appel-Cresswell, Silke
    Vilarino-Guell, Carles
    Encarnacion, Mary
    Sherman, Holly
    Yu, Irene
    Shah, Brinda
    Weir, David
    Thompson, Christina
    Szu-Tu, Chelsea
    Trinh, Joanne
    Aasly, Jan O.
    Rajput, Alex
    Rajput, Ali H.
    Stoessl, A. Jon
    Farrer, Matthew J.
    [J]. MOVEMENT DISORDERS, 2013, 28 (06) : 811 - 813
  • [5] USE OF ANTIHYPERTENSIVES AND THE RISK OF PARKINSON DISEASE
    Ascherio, Alberto
    Tanner, Caroline M.
    [J]. NEUROLOGY, 2009, 72 (06) : 578 - 579
  • [6] Baba M, 1998, AM J PATHOL, V152, P879
  • [7] Depletion of 26S proteasomes in mouse brain neurons causes neurodegeneration and Lewy-like inclusions resembling human pale bodies
    Bedford, Lynn
    Hay, David
    Devoy, Anny
    Paine, Simon
    Powe, Des G.
    Seth, Rashmi
    Gray, Trevor
    Topham, Ian
    Fone, Kevin
    Rezvani, Nooshin
    Mee, Maureen
    Soane, Tim
    Layfield, Robert
    Sheppard, Paul W.
    Ebendal, Ted
    Usoskin, Dmitry
    Lowe, James
    Mayer, R. John
    [J]. JOURNAL OF NEUROSCIENCE, 2008, 28 (33) : 8189 - 8198
  • [8] High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease
    Bender, A
    Krishnan, KJ
    Morris, CM
    Taylor, GA
    Reeve, AK
    Perry, RH
    Jaros, E
    Hersheson, JS
    Betts, J
    Klopstock, T
    Taylor, RW
    Turnbull, DM
    [J]. NATURE GENETICS, 2006, 38 (05) : 515 - 517
  • [9] Ambroxol as a pharmacological chaperone for mutant glucocerebrosidase
    Bendikov-Bar, Inna
    Maor, Gali
    Filocamo, Mirella
    Horowitz, Mia
    [J]. BLOOD CELLS MOLECULES AND DISEASES, 2013, 50 (02) : 141 - 145
  • [10] Chronic systemic pesticide exposure reproduces features of Parkinson's disease
    Betarbet, R
    Sherer, TB
    MacKenzie, G
    Garcia-Osuna, M
    Panov, AV
    Greenamyre, JT
    [J]. NATURE NEUROSCIENCE, 2000, 3 (12) : 1301 - 1306